Press release
Glucagon Like Peptide-1 (GLP-1) Agonists Market 2021 Analysis by Top Manufacturers| Novo Nordisk, AstraZeneca, Eli Lilly, GSK, Sanofi, Bristol-Myers Squibb, Amylin
Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Insights and Forecast to 2027Glucagon Like Peptide-1 (GLP-1) Agonists Market research performs thorough market analysis and uses a variety of sources to provide key players with wide-ranging knowledge about industry strategies. This analysis concentrates more on current trends, market scenario along with depicting dynamic methods and key advancements. All these factors greatly help leading industries to get an advantage over competitive market and leverage their position in the market. Key players of the market focus on following some key strategies such as mergers, acquisitions, collaborations and novel product launches. It further captures actions and plans followed by the competitors in the market to make their business gainful. Glucagon Like Peptide-1 (GLP-1) Agonists Market study discusses about how COVID-19 pandemic affected market growth globally.
The Global Glucagon Like Peptide-1 (GLP-1) Agonists market is expected to register a CAGR of 26.34 % during the forecast period (2021- 2027).
The report introduces the market competition landscape and a detailed analysis of the major suppliers/key players in the market.
Top companies in the global Glucagon Like Peptide-1 (GLP-1) Agonists market: Novo Nordisk, AstraZeneca, Eli Lilly, GSK, Sanofi, Bristol-Myers Squibb, Amylin
INDUSTRY NEWS
AstraZeneca completed the acquisition of Alexion Pharmaceuticals, Inc. (Alexion). The closing of the acquisition marks the Company’s entry into medicines for rare diseases and the beginning of a new chapter for AstraZeneca.
AstraZeneca now has an enhanced scientific presence in immunology and, through Alexion’s innovative complement-biology platform and robust pipeline, will continue to pioneer the discovery and development of medicines for patients with rare diseases. Rare diseases represent a significant unmet medical need and becomes a high-growth opportunity for the Company.
Click on the link to get a free sample copy of the report:
https://www.marketintelligencedata.com/reports/567774/global-glucagon-like-peptide-1-glp-1-agonists-market-insights-and-forecast-to-2027/inquiry?Mode=Radhika
Market Overview
The glucagon-like peptide-1 (GLP-1) agonists market is expected to see a considerable amount of growth during the forecast period. The increase is mainly attributed to the improved efficiency of GLP-1.
Increasing diabetes prevalence in established and emerging countries is expected to drive the market. The increase in the diabetic population over the years is due to the overall effect of individual-level factors, like the increasing median age of the population and health factors, including increasing rates of obesity and inactivity levels among people.
The global Glucagon Like Peptide-1 (GLP-1) Agonists market is divided by product type and application:
The report breaks down the global Glucagon Like Peptide-1 (GLP-1) Agonists market according to the following types:
Exenatied
Liraglutide
Lixisenatide
Albiglutide
Dulaglutide
According to the application, the global Glucagon Like Peptide-1 (GLP-1) Agonists market can be subdivided into:
Hospital
Pharmacy
Other
Regional Outlook of the Glucagon Like Peptide-1 (GLP-1) Agonists market:
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia and Italy)
Asia Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia, etc.)
Middle East and Africa (Saudi Arabia, UAE) , Egypt, Nigeria and South Africa)
North America to Dominate the Market in Terms of Revenue
North America accounts for 77% of the overall GLP-1 market and is expected to witness a growth rate of 6.53%, during the forecast period.
In the Middle East & Africa, the GLP-1 market is expected to see high growth during the forecast period, with a CAGR of 25.08%.
In Asia-Pacific, according to the International Diabetes Federation, Japan and Australia have the highest per capita expenditure, of upwards of USD 3,000. However, China and India have the highest diabetes prevalence.
Buy Now Link
https://www.marketintelligencedata.com/report/purchase/567774?mode=su?Mode=Radhika
The Influence of the Glucagon Like Peptide-1 (GLP-1) Agonists market report:
-Comprehensive assessment of all opportunities and risks in the Glucagon Like Peptide-1 (GLP-1) Agonists market.
-The latest innovations and major events in the Glucagon Like Peptide-1 (GLP-1) Agonists market.
-Research in detail the business strategy of leading enterprises in the Glucagon Like Peptide-1 (GLP-1) Agonists market.
-Conclusive research on the growth chart of the Glucagon Like Peptide-1 (GLP-1) Agonists market in the next few years.
-In-depth understanding of the Glucagon Like Peptide-1 (GLP-1) Agonists market, especially the driving factors, constraints and major micro-markets.
-Have a good impression on the important technologies of the Glucagon Like Peptide-1 (GLP-1) Agonists market and the latest market trends.
Browse the report description and table of contents:
https://www.marketintelligencedata.com/reports/567774/global-glucagon-like-peptide-1-glp-1-agonists-market-insights-and-forecast-to-2027?Mode=Radhika
Key Highlights of the Glucagon Like Peptide-1 (GLP-1) Agonists Market Report
Market Segments and other perspectives have been studied across 3600 perspectives
Both Supply and Demand-side mapping has been done to understand the market scenario
We have used data triangulation to derive the market numbers
Our data and analysis have been verified through C-level Executives while conducting primary interviews
Porter’s Five Forces Analysis, Swot, Analysis, PEST Analysis, Value Chain Analysis and Market Attractiveness would be an added advantage in the report
Historical Year: 2016; Base Year: 2021; Forecast Years: 2021 – 2027
We will get in touch with you within 24hrs and help you find the research reports and Additional Customization you need.
About Us:
Market intelligence data is a global front-runner in the research industry, offering contextual and data-driven research services to customers. Customers are supported in creating business plans and attaining long-term success in their respective marketplaces by the organization. The industry provides consulting services, Market Intelligence Data research studies, and customized research reports.
Contact Us:
Irfan Tamboli (Head of Sales) – MARKET INTELLIGENCE DATA
Phone: +1 (704) 266-3234
Mail to: sales@marketintelligencedata.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Glucagon Like Peptide-1 (GLP-1) Agonists Market 2021 Analysis by Top Manufacturers| Novo Nordisk, AstraZeneca, Eli Lilly, GSK, Sanofi, Bristol-Myers Squibb, Amylin here
News-ID: 2472143 • Views: …
More Releases from Market Insights Reports
Cold Chain Monitoring Market May See a Big Move | BlueAir, Denso, Eureka Forbes, …
Market Insights Reports published a new research publication on "Cold Chain Monitoring Market Insights, to 2032" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Cold Chain Monitoring market was mainly driven by the increasing R&D spending across the world.
Some of the key players…
Outbound Logistics Market Next Big Thing | Major Giants- Draexlmaier, Faurecia, …
Market Insights Reports published a new research publication on "Outbound Logistics Market Insights, to 2032" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Outbound Logistics market was mainly driven by the increasing R&D spending across the world.
Some of the key players profiled in…
Veterinary Telemedicine Market May See a Big Move | Nestle, Deuerer, The J.M. Sm …
Market Insights Reports published a new research publication on "Veterinary Telemedicine Market Insights, to 2032" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Veterinary Telemedicine market was mainly driven by the increasing R&D spending across the world.
Some of the key players profiled in…
Precision Planting Market is Set to Fly High in Years to Come
Market Insights Reports published a new research publication on "Precision Planting Market Insights, to 2032" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Precision Planting market was mainly driven by the increasing R&D spending across the world.
Some of the key players profiled in…
More Releases for Glucagon
Escalating Diabetes Prevalence Drives The Global Glucagon-Like Peptide 1 Market: …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Glucagon-like Peptide 1 Market Size By 2025?
The market size for glucagon-like peptide 1 has experienced robust growth in the past few years. It is projected to increase from $20.88 billion in 2024 to $22.37 billion in 2025, with a compound annual growth rate (CAGR)…
Glucagon Injection Market Size And Global Industry Forecast 2034
On May 12 , 2025, Exactitude Consultancy., Ltd. released a research report titled "Glucagon Injection Market". This report covers the global Glucagon Injection market sales, sales volume, price, market share, ranking of major companies, etc., and provides a detailed analysis by region, country, product type, and application. It also forecasts the market size of automotive kick sensors based on market patterns from 2020 to 2034 and future market trends. Along…
Top Factor Driving Glucagon-like Peptide 1 Market Growth in 2025: Escalating Dia …
"How Are the key drivers contributing to the expansion of the glucagon-like peptide 1 market?
The global glucagon-like peptide 1 market is predicted to be bolstered by the increasing occurrence of diabetes. Diabetes characterizes a condition where there is an excess of blood sugar or blood glucose. The medical treatment of conditions such as type 2 diabetes, which could result in weight loss and better control of blood sugar, uses glucagon-like…
Top Factor Driving Glucagon-like Peptide 1 Market Growth in 2025: Escalating Dia …
How Are the key drivers contributing to the expansion of the glucagon-like peptide 1 market?
The global glucagon-like peptide 1 market is predicted to be bolstered by the increasing occurrence of diabetes. Diabetes characterizes a condition where there is an excess of blood sugar or blood glucose. The medical treatment of conditions such as type 2 diabetes, which could result in weight loss and better control of blood sugar, uses glucagon-like…
Glucagon Market Trends, Segmentation, Growth, Analysis and Forecast 2023-2029
The global glucagon market is anticipated to grow at a considerable CAGR of 5.9% during the forecast period. Glucagon is a metabolic hormone that increases the glucose level in the blood with the support of the liver which rapidly converts glycogen into glucose. The glucagon is secreted by the pancreas, which is further converted into glucose and released in the blood. It is basically used in the treatment of disorders…
Glucagon Market Trends, Research Report, Growth, Opportunities and Forecast 2023 …
The global glucagon market is anticipated to grow at a considerable CAGR of 5.9% during the forecast period. Glucagon is a metabolic hormone that increases the glucose level in the blood with the support of the liver which rapidly converts glycogen into glucose. The glucagon is secreted by the pancreas, which is further converted into glucose and released in the blood. It is basically used in the treatment of disorders…
